<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>17462198</identifier>
<setSpec>0025-7753</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Martínez-Frías, María Luisa</dc:author>
<dc:author>Fernández Martín, Paloma</dc:author>
<dc:author>Rodríguez-Pinilla, Elvira</dc:author>
<dc:author>Mejías, Consuelo</dc:author>
<dc:description xml:lang="en">Selective Serotonin Reuptake Inhibitors (SSRIs) have become the drug of choice for the treatment of depression and have shown to be effective in the treatment for other mental disorders. Recently, several articles have reported about the adverse effects observed in newborns after maternal exposure to these drugs during the last trimester of pregnancy. In this work, a review of literature is presented, regarding the above mentioned adverse effects. Moreover, some guidelines for the rational use of these drugs during the last trimester of pregnancy and for the management of prenatally exposed newborns are provided.</dc:description>
<dc:type>English Abstract</dc:type>
<dc:language>es</dc:language>
<dc:date>2007 Apr 21 </dc:date>
<dc:title xml:lang="es">Efectos adversos de los inhibidores selectivos de la recaptación de serotonina durante el tercer trimestre de la gestación y guías de prevención.</dc:title>
<dc:title xml:lang="en">[Adverse effects of selective serotonin reuptake inhibitors use during the third trimester of pregnancy and prevention guidelines].</dc:title>
<dc:publisher>Medicina clinica</dc:publisher>
</metadata>
</record>
</pubmed-document>
